Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil. - Wikidata - awgldk - TriplyDB

Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.

Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.

http://www.wikidata.org/entity/Q43050549

about

Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group.Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide Phase I and pharmacokinetic study of D-verapamil and doxorubicin.Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma.R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.

P2860

Q35976246-0D6DD988-864B-4FC6-A3D1-E88DA5B7C02A Q35976932-1D7DCC39-CCB0-4D8E-AF75-22B9849647C8 Q35977382-91E1F2FE-97BB-4D6A-9734-7156411A147A Q35992779-0C303F91-FC58-4511-BA57-D4E0638933A9 Q35993988-2ECEC63E-C98C-41C7-9463-C3719C402988 Q35994246-A8281B80-AF82-4E10-844B-B9F6C8A5167B Q36080770-DE1944A5-D858-481C-AD47-8DB87DB094E1 Q36292342-78279975-1DFF-4179-984C-FE52E0AB8D7B Q41027272-CFFB7E5A-E7F2-4D61-BB2B-B19611BD4C92 Q43201462-1556D7F7-E894-4781-8917-0069A5747105

P2860

Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.

http://www.wikidata.org/entity/Q43050549

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年学术文章

@wuu

1989年学术文章

@zh

1989年学术文章

@zh-cn

1989年学术文章

@zh-hans

1989年学术文章

@zh-my

1989年学术文章

@zh-sg

1989年學術文章

@yue

1989年學術文章

@zh-hant

name

Inherent adriamycin resistance ...... th verapamil and norverapamil.

@en

Inherent adriamycin resistance ...... th verapamil and norverapamil.

@nl

type

label

Inherent adriamycin resistance ...... th verapamil and norverapamil.

@en

Inherent adriamycin resistance ...... th verapamil and norverapamil.

@nl

prefLabel

Inherent adriamycin resistance ...... th verapamil and norverapamil.

@en

Inherent adriamycin resistance ...... th verapamil and norverapamil.

@nl

P1433

Q43050549-BE096F84-5077-4C58-8BD3-3588C5444591

P1476

Q43050549-569109C7-79B9-485C-8D18-ACCBCE4A07A3

P2093

Q43050549-43C11D5F-5271-49D3-B42E-12EDB3C6FF28

Q43050549-467AD702-7390-48D4-991F-E3B0A7DEAC33

Q43050549-BADE947B-C48B-464D-8639-997F37194EDC

Q43050549-C820C8BB-5C6B-4CF8-B665-D382C092D3D3

Q43050549-EB27B3B1-3D30-4259-AF65-FD6176CF301D

P2860

Q43050549-18FD2F62-9D57-49B9-815B-2C51EBE95C11

Q43050549-1AB3F960-F9C8-4446-A25C-69AF0168FA52

Q43050549-22A7071E-22B8-497A-A2DC-B0D7754C7828

Q43050549-6D37A1F5-6D39-4D15-A248-ECF4E628013E

Q43050549-E15AC13D-BA36-46CD-8695-E203ACFC5C7B

Q43050549-E1703F7D-7B72-493A-AD79-E6FBAE793B53

Q43050549-E456D713-CBD4-4623-A288-1B8288BF8692

Q43050549-FF2C310E-C6D1-47E0-A16D-FA21680DF807

P2888

Q43050549-AE92B6D6-EBB4-48F9-90AD-509FA00F1119

P304

Q43050549-4DD0B9B2-D3A8-4759-AE82-0305D84102DF

P31

Q43050549-BAA2F2D6-D69B-40F0-81BF-0C3AC69E54D8

P356

Q43050549-4CB50460-8424-4933-BA3E-48E1BA70F37A

P407

Q43050549-39A68CF1-5E7C-4CE2-B69E-EE3FC5FE0065

P433

Q43050549-545AE69E-2369-4E62-9D67-67ED86275CD3

P478

Q43050549-140AB03D-BB11-424F-B434-D15B61D5BD35

P577

Q43050549-95C1679D-6F5D-43C0-943A-0BD08F9764C3

P5875

Q43050549-B6D8AA51-7A5B-4351-ABF3-454025155A96

P698

Q43050549-E7561987-CFBF-4BD0-B94B-5B941D8CCE67

P932

Q43050549-986DF7C0-3E3F-465E-9FB0-55C02A8BB832

P356

P1433

British Journal of Cancer

P1476

Inherent adriamycin resistance ...... th verapamil and norverapamil.

@en

P2093

Flanigan P

http://www.w3.org/2001/XMLSchema#string

Freshney RI

http://www.w3.org/2001/XMLSchema#string

Kaye SB

http://www.w3.org/2001/XMLSchema#string

Merry S

http://www.w3.org/2001/XMLSchema#string

Schlick E

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.

Tumour cell resistance to anthracyclines--a review.

Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

Cross-resistance to cytotoxic drugs in human glioma cell lines in culture.

The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog.

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.

P2888

P304

895-897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1989.189

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

1989-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20420462

http://www.w3.org/2001/XMLSchema#string

P698

2736226

http://www.w3.org/2001/XMLSchema#string

P932

2246748

http://www.w3.org/2001/XMLSchema#string